Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Myelogenous Leukemia (CML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00083070
What this trial is testing

Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT00006225
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+2 more
Northwestern University
Large-scale testing (Phase 3)Study completedNCT00002868
What this trial is testing

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 744
Large-scale testing (Phase 3)Study completedNCT03480360
What this trial is testing

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Dartmouth-Hitchcock Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00053248
What this trial is testing

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT00052520
What this trial is testing

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+20 more
Fred Hutchinson Cancer Center 37
Not applicableStudy completedNCT01188278
What this trial is testing

Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey

Who this might be right for
Leukemia, Myeloid, Chronic-Phase (CML-CP)
Bristol-Myers Squibb 173
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Not applicableStudy completedNCT03045120
What this trial is testing

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 118
Not applicableStudy completedNCT05476562
What this trial is testing

Study Conducted Among Patients With CML

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 3,234
Testing effectiveness (Phase 2)Study completedNCT01036009
What this trial is testing

Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more
University of California, San Francisco 43
Testing effectiveness (Phase 2)Study completedNCT02353728
What this trial is testing

Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Weill Medical College of Cornell University 16
Not applicableStudy completedNCT01768845
What this trial is testing

Unrelated Umbilical Cord Blood (UBC)Transplantation

Who this might be right for
Chronic Myelogenous Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome+6 more
West Virginia University 34
Early research (Phase 1)Study completedNCT01374139
What this trial is testing

Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects

Who this might be right for
Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)
Pfizer 88
Not applicableStudy completedNCT00126477
What this trial is testing

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 750
Large-scale testing (Phase 3)Ended earlyNCT01366612
What this trial is testing

Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

Who this might be right for
Myeloid MalignanciesAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
Hackensack Meridian Health 53
Testing effectiveness (Phase 2)Study completedNCT00003336
What this trial is testing

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00114257
What this trial is testing

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
National Cancer Institute (NCI) 36
Next Page